Literature DB >> 30846068

Response.

Lukas Martin1, Matthias Derwall2, Sura Al Zoubi3, Elisabeth Zechendorf2, Daniel A Reuter4, Chris Thiemermann3, Tobias Schuerholz4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30846068      PMCID： PMC6435895          DOI： 10.1016/j.chest.2018.10.018

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Use of a Short-Acting β1 Blocker During Endotoxemia May Reduce Cerebral Tissue Oxygenation if Hemodynamics are Depressed by a Decrease in Heart Rate.

Authors:  Tadayoshi Kurita; Shingo Kawashima; Koji Morita; Yoshiki Nakajima
Journal:  Shock       Date:  2017-06       Impact factor: 3.454

Review 2.  The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications.

Authors:  Lukas Martin; Matthias Derwall; Sura Al Zoubi; Elisabeth Zechendorf; Daniel A Reuter; Chris Thiemermann; Tobias Schuerholz
Journal:  Chest       Date:  2018-08-29       Impact factor: 9.410

Review 3.  Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?

Authors:  Konstantinos Drosatos; Anastasios Lymperopoulos; Peter Johannes Kennel; Nina Pollak; P Christian Schulze; Ira J Goldberg
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 4.  Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis.

Authors:  Takeshi Suzuki; Yuta Suzuki; Jun Okuda; Takuya Kurazumi; Tomohiro Suhara; Tomomi Ueda; Hiromasa Nagata; Hiroshi Morisaki
Journal:  J Intensive Care       Date:  2017-03-03

5.  Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression.

Authors:  Christian A Schmittinger; Martin W Dünser; Maria Haller; Hanno Ulmer; Günter Luckner; Christian Torgersen; Stefan Jochberger; Walter R Hasibeder
Journal:  Crit Care       Date:  2008-08-04       Impact factor: 9.097

6.  α2A-adrenergic blockade attenuates septic cardiomyopathy by increasing cardiac norepinephrine concentration and inhibiting cardiac endothelial activation.

Authors:  Xiaohui Yu; Yuan Wang; Duomeng Yang; Xiangxu Tang; Hongmei Li; Xiuxiu Lv; Renbin Qi; Chaofeng Hu; Daxiang Lu; Ben Lv; Huadong Wang
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.